Thursday, March 28, 2024

TOPICS

Home Authors Posts by Ryan Flinn

Ryan Flinn

5 POSTS 0 COMMENTS
AMGEN INC. saw its net income increase 21 percent to $1.4 billion, or $1.88 per share, during the first quarter, the biotech company reported after markets closed on Tuesday. / BLOOMBERG FILE PHOTO

Amgen tops analyst estimates as profit benefits from tax credit

SAN FRANCISCO - Amgen Inc., which has a production facility in West Greenwich, reported first-quarter profit that beat analyst estimates because of a research...
AMGEN INC. saw its profits beat out estimates in the fourth quarter, while its net income dropped 16 percent to $788 million.  / BLOOMBERG FILE PHOTO

Amgen tops profit estimates on sales of arthritis, bone drugs

SAN FRANCISCO - Amgen Inc., the world’s largest biotechnology companies, reported fourth-quarter profit that beat analyst estimates as sales of arthritis and bone drugs...
AMGEN INC. is developing a new anti-cholesterol medicine as its rivals chase after increased sales.  / BLOOMBERG FILE PHOTO

Amgen places bet on heart drug as rivals go after sales

SAN FRANSISCO - Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best...

Amgen’s cancer sales to grow in 2012, CEO-to-be reports

SAN FRANCISCO - Amgen Inc.,the world’s largest biotechnology company with a facility in West Greenwich, will see revenue accelerate this year as sales of...

Alexion to pay as much as $1.08 billion to buy Enobia

SAN FRANCISCO - Alexion Pharmaceuticals Inc., the maker of a drug for a rare blood disease, agreed to acquire closely held Enobia Pharma Corp....
- Featured Event -

Latest News